2024-01-19 PUT at $12.5 Option on Immunoprecise Antibodies

IPA
 Stock
  

USD 6.32  0.06  0.94%   

2024-01-19 PUT at $12.5 is a PUT option contract on Immunoprecise Antibodies' common stock with a strick price of 12.5 expiring on 2024-01-19. The contract was last traded on 2022-08-16 at 14:50:18 for $7.7 and, as of today, has 519 days remaining before the expiration. The option is currently trading at a bid price of $6.4, and an ask price of $8.6. The implied volatility as of the 18th of August 2022 is 99.3341.
  
Please see Risk vs Return Analysis.
A put option written on Immunoprecise Antibodies becomes more valuable as the price of Immunoprecise Antibodies drops. Conversely, Immunoprecise Antibodies' put option loses its value as Immunoprecise Stock rises. When exercised, put options on Immunoprecise Antibodies produce a short position in Immunoprecise Stock. Because of this protective nature, they are typically used either for hedging purposes or to capitalize on Immunoprecise Antibodies' downside price movement.

Rule 16 of 2024-01-19 Option Contract

The options market is anticipating that Immunoprecise Antibodies will have an average daily up or down price movement of about 6.21% per day over the life of the option. With Immunoprecise Antibodies trading at $6.32, that is roughly $0.39. If you think that the market is fully understating Immunoprecise Antibodies' daily price movement you should consider buying Immunoprecise Antibodies options at that current volatility level of 99.33%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

In The Money Put Option on Immunoprecise Antibodies

An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Immunoprecise Antibodies positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Immunoprecise Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Put Contract Name2024-01-19 PUT at $12.5
Expires On2024-01-19
Days Before Expriration519
Last Traded On2022-08-16 14:50:18
Contract PeriodMONTHLY
Open Interest190
Current Trading Volume30.0
Strike Price12.5
Last Traded At7.7
Current Price Spread6.4 | 8.6
Rule 16 Daily Up or Down$0.39

Immunoprecise short PUT Option Greeks

Immunoprecise Antibodies' Option Greeks for the contract ending on 2024-01-19 at a strike price of 12.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Immunoprecise Antibodies' option greeks, its implied volatility helps estimate the risk of Immunoprecise Antibodies stock implied by the prices of the options on Immunoprecise Antibodies' stock.
Delta-0.4961
Gamma0.0547
Theta-0.0023
Vega0.0299
Rho-0.0916

Immunoprecise long PUT Option Payoff at expiration

Put options written on Immunoprecise Antibodies grant holders of the option the right to sell a specified amount of Immunoprecise Antibodies at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Immunoprecise Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Immunoprecise Antibodies is like buying insurance aginst Immunoprecise Antibodies' downside shift.
   Profit   
Share
       Immunoprecise Antibodies Price At Expiration  

Immunoprecise short PUT Option Payoff at expiration

By selling Immunoprecise Antibodies' put option, the investors signal their bearish sentiment. A short position in a put option written on Immunoprecise Antibodies will generally make money when the underlying price is above the strike price. Therefore Immunoprecise Antibodies' put payoff at expiration depends on where the Immunoprecise Stock price is relative to the put option strike price. The breakeven price of 5.0 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Immunoprecise Antibodies' price. Finally, at the strike price of 12.5, the payoff chart is constant and positive.
   Profit   
Share
       Immunoprecise Antibodies Price At Expiration  
View All Immunoprecise Antibodies Options

Immunoprecise Antibodies Available Put Options

Immunoprecise Antibodies' option chain is a display of a range of information that helps investors for ways to trade options on Immunoprecise. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Immunoprecise. It also shows strike prices and maturity days for a Immunoprecise Antibodies against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
 Put
2022-08-19 PUT at $7.5-0.49590.108372022-08-190.7 - 3.71.9In
 Put
2022-08-19 PUT at $10.0-0.57740.079412022-08-193.3 - 6.04.8In

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
161.2 M
Quarterly Revenue Growth YOY
0.074
Return On Assets
-0.13
Return On Equity
-0.25
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.